570 related articles for article (PubMed ID: 24700657)
1. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol.
Larochelle MB; Phan R; Craddock J; Abzug MJ; Curtis D; Robinson CC; Giller RH; Cosgrove S; Siringo F; McCourt E; Palestine AG
Am J Ophthalmol; 2017 Mar; 175():8-15. PubMed ID: 27746296
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
[TBL] [Abstract][Full Text] [Related]
5. The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients.
Mo W; Chen X; Zhang X; Wang S; Li L; Zhang Y
Front Cell Infect Microbiol; 2022; 12():900154. PubMed ID: 35694535
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.
Wu JL; Ma HY; Lu CY; Chen JM; Lee PI; Jou ST; Yang YL; Chang HH; Lu MY; Chang LY; Huang LM
J Microbiol Immunol Infect; 2017 Jun; 50(3):307-313. PubMed ID: 26346369
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
[TBL] [Abstract][Full Text] [Related]
8. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
10. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation.
Zöllner SK; Herbrüggen H; Kolve H; Mihailovic N; Schubert F; Reicherts C; Rössig C; Groll AH
Transpl Infect Dis; 2019 Oct; 21(5):e13089. PubMed ID: 30972869
[TBL] [Abstract][Full Text] [Related]
12. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
[TBL] [Abstract][Full Text] [Related]
13. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
[TBL] [Abstract][Full Text] [Related]
15. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative monitoring of blood cytomegalovirus after allogeneic hematopoietic stem cell transplantation and its clinical significance].
Qiu ZX; Wang MJ; Wang LH; Sun YH; Xu WL; Liu W; Ou JP; Dong YJ; Li Y; Liang ZY; Cen XN; Ren HY
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):371-5. PubMed ID: 22883336
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
[TBL] [Abstract][Full Text] [Related]
18. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation.
Jaing TH; Chang TY; Chen SH; Wen YC; Yu TJ; Lee CF; Yang CP; Tsay PK
Medicine (Baltimore); 2019 Jan; 98(4):e14172. PubMed ID: 30681583
[TBL] [Abstract][Full Text] [Related]
20. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
